{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:25:48Z","timestamp":1761823548190},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,15]]},"DOI":"10.1093\/infdis\/jit155","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T01:49:58Z","timestamp":1365472198000},"page":"275-283","source":"Crossref","is-referenced-by-count":33,"title":["Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV)"],"prefix":"10.1093","volume":"208","author":[{"given":"Kenji","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Kino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuo","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohji","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,4,8]]},"reference":[{"key":"key\n\t\t\t\t20170702150527_JIT155C1","article-title":"Wild Poliovirus 2007\u20132012","author":"WHO"},{"key":"key\n\t\t\t\t20170702150527_JIT155C2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.7883\/yoken.JJID.2008.100","article-title":"Poisson-model analysis of the risk of vaccine-associated paralytic poliomyelitis in Japan between 1971 and 2000","volume":"61","author":"Hao","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"key\n\t\t\t\t20170702150527_JIT155C3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/B978-1-4160-3611-1.50030-1","article-title":"Poliovirus vaccine-live","volume-title":"Vaccines","author":"Sutter","year":"2008","edition":"5th ed"},{"key":"key\n\t\t\t\t20170702150527_JIT155C4","article-title":"WHO global action plan to minimize poliovirus facility-associated risk after eradication of wild polioviruses and cessation of routine OPV use"},{"key":"key\n\t\t\t\t20170702150527_JIT155C5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biologicals.2006.02.011","article-title":"Technology transfer of Sabin-IPV to new developing country markets","volume":"34","author":"Kreeftenberg","year":"2006","journal-title":"Biologicals"},{"key":"key\n\t\t\t\t20170702150527_JIT155C6","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"Bakker","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702150527_JIT155C7","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00006454-198811000-00003","article-title":"Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey","volume":"7","author":"Murph","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170702150527_JIT155C8","first-page":"163","article-title":"Progress with inactivated poliovirus vaccines derived from the Sabin strains","volume":"105","author":"Doi","year":"2001","journal-title":"Dev Biol (Basel)"},{"key":"key\n\t\t\t\t20170702150527_JIT155C9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir723","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial","volume":"205","author":"Liao","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702150527_JIT155C10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.biologicals.2006.02.010","article-title":"Development of inactivated poliovirus vaccine derived from Sabin strains","volume":"34","author":"Simizu","year":"2006","journal-title":"Biologicals"},{"key":"key\n\t\t\t\t20170702150527_JIT155C11","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0264-410X(98)00409-5","article-title":"Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains","volume":"17","author":"Kersten","year":"1999","journal-title":"Vaccine"},{"issue":"Suppl","key":"key\n\t\t\t\t20170702150527_JIT155C12","first-page":"59","article-title":"Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin","volume":"13","author":"Ginnaga","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"key":"key\n\t\t\t\t20170702150527_JIT155C13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1442-200X.1995.tb03378.x","article-title":"Immunogenicity and reactogenicity of the component acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous haemagglutinin","volume":"37","author":"Kimura","year":"1995","journal-title":"Acta Paediatr Jpn"},{"key":"key\n\t\t\t\t20170702150527_JIT155C14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/0264-410X(95)00257-2","article-title":"Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age","volume":"14","author":"Huang","year":"1996","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702150527_JIT155C15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1442-200x.2004.01970.x","article-title":"Safety and efficacy of acellular pertussis vaccine in Japan, evaluated by 23 years of its use for routine immunization","volume":"46","author":"Kuno-Sakai","year":"2004","journal-title":"Pediatr Int"},{"key":"key\n\t\t\t\t20170702150527_JIT155C16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1017\/S0950268808000708","article-title":"Effectiveness of an acellular pertussis vaccine in Japanese children during a non-epidemic period: a matched case-control study","volume":"137","author":"Okada","year":"2009","journal-title":"Epidemiol Infect"},{"key":"key\n\t\t\t\t20170702150527_JIT155C17","article-title":"Manual for the virological investigation of poliomyelitis"},{"key":"key\n\t\t\t\t20170702150527_JIT155C18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/B978-1-4160-3611-1.50029-5","article-title":"Poliovirus vaccine-inactivated","volume-title":"Vaccines","author":"Plotkin","year":"2008","edition":"5th ed"},{"key":"key\n\t\t\t\t20170702150527_JIT155C19","first-page":"2275","article-title":"DPT","volume":"53","author":"Kato","year":"1990","journal-title":"J Pediatr Practice"},{"key":"key\n\t\t\t\t20170702150527_JIT155C20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-1-4160-3611-1.50014-3","article-title":"Diphtheria toxoid","volume-title":"Vaccines","author":"Vitek","year":"2008","edition":"5th ed"},{"key":"key\n\t\t\t\t20170702150527_JIT155C21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/B978-1-4160-3611-1.50035-0","article-title":"Tetanus toxoid","volume-title":"Vaccines","author":"Wassilak","year":"2008","edition":"5th ed"},{"key":"key\n\t\t\t\t20170702150527_JIT155C22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00000441-195506000-00001","article-title":"Evaluation of 1954 field trial of poliomyelitis vaccine: synopsis of summary report","volume":"229","author":"Francis","year":"1955","journal-title":"Am J Med Sci"},{"key":"key\n\t\t\t\t20170702150527_JIT155C23","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jama.1961.03040130043010","article-title":"Effectiveness of Salk vaccine. Analysis of virologically confirmed cases of paralytic and nonparalytic poliomyelitis","volume":"175","author":"Melnick","year":"1961","journal-title":"J Am Med Assoc"},{"key":"key\n\t\t\t\t20170702150527_JIT155C24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(88)91711-4","article-title":"Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine","volume":"331","author":"Robertson","year":"1988","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170702150527_JIT155C25","first-page":"1272","article-title":"Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 4. Final report of results based on clinical diagnoses","volume":"151","author":"Hammon","year":"1953","journal-title":"J Am Med Assoc"},{"key":"key\n\t\t\t\t20170702150527_JIT155C26","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/424524","article-title":"Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy","volume":"190","author":"Dragunsky","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702150527_JIT155C27","article-title":"Confirmed international spread of wild poliovirus from Pakistan","author":"WHO"},{"key":"key\n\t\t\t\t20170702150527_JIT155C28","article-title":"WHO International Standard Anti-Measles Serum, Human and Anti-Poliovirus serum Types 1,2 and 3. (66\/202)","author":"National Institute for Biological Standards and Control"},{"key":"key\n\t\t\t\t20170702150527_JIT155C29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/oxfordjournals.aje.a115009","article-title":"Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccine","volume":"128","author":"McBean","year":"1988","journal-title":"Am J Epidemiol."}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/208\/2\/275\/18069283\/jit155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T14:34:15Z","timestamp":1715178855000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jit155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,8]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,4,8]]},"published-print":{"date-parts":[[2013,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jit155","relation":{},"ISSN":["1537-6613","0022-1899"],"issn-type":[{"value":"1537-6613","type":"electronic"},{"value":"0022-1899","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,8]]}}}